No Detail Found!

Covid-19 and Fungal Infection: A literature review

Author(s)
Darmadi Darmadi Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Cennikon Pakpahan Department of Biomedical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Sem Samuel Surja Department of Parasitology, School of Medicine and Health Sciences, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia
Abstract
Fungal infections have emerged as a significant and potentially lethal complication in critically ill patients with Covid-19. Infections caused by Aspergillus, Candida, and Mucormycetes, are a common cause of morbidity and mortality in critically ill patients, especially those with preexisting comorbidities. The underlying mechanisms that predispose fungal infections are not fully understood, but the use of corticosteroids, underlying conditions, prolonged hospitalization, and antibiotic are several factors that might be associated. They are associated with higher mortality rates, increased healthcare costs, delayed recovery, and prolonged hospitalization. Antifungal therapy for COVID-19-associated fungal infections can interact with other drugs used to treat COVID-19, which can complicate management. The emergence of antifungal resistance is a concern for the management of COVID-19-associated fungal infections.
Publication Details
Page(s) 795-798
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 48, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Mucormycosis, Pulmonary aspergillosis, invasive candidiasis, coronavirus.
References
Ruslie RH,Darmadi D,Siregar GA .2020 .. Pediatric Immunization Practice During Coronavirus Disease-2019 Pandemic. Open Access Maced J Med Sci, 8(T1) : 258-60.
Ruslie RH,Darmadi D,Siregar GA .2020 .. Susceptibility of Coronavirus Disease-19 in Pediatric Population. Open Access Maced J Med Sci, 8(T1) : 353-5.
Siregar GA,Siregar GP,Darmadi D,Ruslie RH,Injury Liver .2020 .. Open Access Maced J Med Sci, 8(T1) : 154-7.
Darmadi D,Ruslie RH .2020 .. Coronavirus Disease-2019 and Mental Health. Open Access Maced J Med Sci, 8(T1) : 268-71.
Siregar GA,Siregar GP,Darmadi D,Review A .2020 .. Open Access Maced J Med Sci, 8(T1) : 52-4.
Domán M,Bányai K. COVID- M .2022 .. -Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach? Front Microbiol, 13 : 919501.
Islam MR,Rahman MM,Ahasan MT,Sarkar N,Akash S,Islam M .2022 .The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance. Environ Sci Pollut Res Int, 29 : 69341-66.
Sharma A,Hofmeyr A,Bansal A,Thakkar D,Lam L,Harrington Z .2021 .. COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report. Med Mycol Case Rep, 31 : 6-10.
Ayalon O,Cohen MJ,Orenbuch-Harroch E,Sviri S,van Heerden PV,Korem M. .2022 .Invasive fungal infections in critically ill COVID-19 patients in a large tertiary university hospital in Israel. J Crit Care, 69 : 154004.
Raffaelli F,Tanzarella ES,De Pascale G,Tumbarello M. .2022 .Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients. J Fungi, 8 : 415-8.
Shishido AA,Mathew M,Baddley JW .2022 .. Overview of COVID-19-Associated Invasive Fungal Infection. Curr Fungal Infect Rep, 16 : 87-97.
Koehler P,Cornely OA,Böttiger BW,Dusse F,Eichenauer DA,Fuchs F .2020 .-19 associated pulmonary aspergillosis. Mycoses, 63 : 528-34.
White pL,Dhillon R,Cordey A,Hughes H,Faggian F,Soni S .2021 .National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit. Clin Infect Dis, 73 : e1634-e1644.
Egger M,Bussini L,Hoenigl M,Bartoletti M.,Conclusions. J Fungi M. .2022 .Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review. , 8 : 390-5.
Wasylyshyn AI,Wasylyshyn GR,Linder KA,Miceli MH,-Associated Pulmonary MH .2021 .Aspergillosis at an Academic Medical Center in the Midwestern United States. Mycopathologia, 186 : 499-505.
de Brabander J,Boers LS,Kullberg RF,Duitman JW,Bos LD .2022 .ArtDeco consortium. Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis. Lancet Respir Med, 10 : e25-e26.
Song G,Liang G,Liu W. Fungal .2020 .Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia, 185 : 599-606.
van Arkel AL,Rijpstra TA,Belderbos HN,van Wijngaarden P,Verweij PE,Bentvelsen RG,- associated Pulmonary,Aspergillosis Pulmonary .2020 .. Am J Respir Crit Care Med, 202 : 132-5.
Verweij PE,Rijnders BJ,Brüggemann RJ,Azoulay E,Bassetti M,Blot S .2020 .Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med, 46 : 1524-35.
Lamoth F,Lewis RE,Walsh TJ,Kontoyiannis DP,-Associated Aspergillosis A Comparison,With Influenza-Associated Aspergillosis A Comparison .2021 .. J Infect Dis, 224 : 1631-40.
Meijer EF,Dofferhoff AS,Hoiting O,Buil JB,Meis JF,Azole-Resistant COVID .2020 .. -Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report. J Fungi (Basel), 6 : 79-84.
0

Citations

0

Downloads

59

Views